Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2017-11-03
Original SEC Filing: Click here

---

Webplus: SVA/20171103/6-K/2_EX-99.1/000.htm SEC Original: tv478546_ex99-1.htm
Sinovac Biotech Announces Receipt of Delisting Determination Letter from Nasdaq BEIJING, November 3, 2017 /PRNewswire/ — Sinovac Biotech Ltd. (Nasdaq: SVA)(”Sinovac”), a leading provider of biopharmaceutical products in China, announced today that on November 1, 2017, the Company received a delisting determination letter from the Staff of the Listing Qualifications Department (the “LQ Staff”) of The Nasdaq Stock Market, Inc.

---

---

Webplus: SVA/20171103/6-K/1/000.htm SEC Original: tv478546_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2017-11-03CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD, HAIDIAN DISTRICT
BEIJING 100085